0001104659-24-073950.txt : 20240621
0001104659-24-073950.hdr.sgml : 20240621
20240621162011
ACCESSION NUMBER: 0001104659-24-073950
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20240620
FILED AS OF DATE: 20240621
DATE AS OF CHANGE: 20240621
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Seizinger Bernd R.
CENTRAL INDEX KEY: 0001789042
ORGANIZATION NAME:
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-39069
FILM NUMBER: 241060682
MAIL ADDRESS:
STREET 1: 535 BOYLSTON STREET
CITY: BOSTON
STATE: MA
ZIP: 02116
FORMER NAME:
FORMER CONFORMED NAME: Seizinger Bernd
DATE OF NAME CHANGE: 20190923
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Aprea Therapeutics, Inc.
CENTRAL INDEX KEY: 0001781983
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
ORGANIZATION NAME: 03 Life Sciences
IRS NUMBER: 000000000
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 3805 OLD EASTON ROAD
CITY: DOYLESTOWN
STATE: PA
ZIP: 18902
BUSINESS PHONE: 617-463-9385
MAIL ADDRESS:
STREET 1: 3805 OLD EASTON ROAD
CITY: DOYLESTOWN
STATE: PA
ZIP: 18902
4
1
tm2417666-6_4seq1.xml
OWNERSHIP DOCUMENT
X0508
4
2024-06-20
0
0001781983
Aprea Therapeutics, Inc.
APRE
0001789042
Seizinger Bernd R.
3805 OLD EASTON ROAD
DOYLESTOWN
PA
18902
1
0
0
0
0
Common Stock
2024-06-20
4
A
0
1045
0.00
A
34730
D
Stock Options (Right to Buy)
4.07
2024-06-20
4
A
0
4185
0.00
A
2034-06-20
Common Stock
4185
4185
D
These shares represent restricted stock units which were granted on June 20, 2024, and which will vest and be settled in common stock on June 20, 2025, subject to the reporting person's continued service on the Issuer's board of directors through and including the applicable vesting date and subject to acceleration under certain conditions.
The option vests in full on June 20, 2025, subject to the reporting person's continued service on the Issuer's board of directors through and including the applicable vesting date and subject to acceleration under certain conditions.
/s/ John Hamill, as Attorney-in-Fact
2024-06-21